XOMAP FY 2020 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+60.0% YoY

Gross Profit

$29M99.4% margin

Operating Income

$12M42.3% margin

Net Income

$13M45.3% margin

EPS (Diluted)

$0.78

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$125M

Total Liabilities

$39M

Stockholders' Equity

$86M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$18M	+60.0%
Gross Profit	$29M	$17M	+70.7%
Operating Income	$12M	-$4M	+419.6%
Net Income	$13M	-$2M	+770.9%